I'm not a biomedical scientist but I do software / analysis to support drug discovery groups. >Is oncology moving by continuous small steps or via leaps after

I'm not a biomedical scientist but I do software / analysis to support drug discovery groups. >Is oncology moving by continuous small steps or via leaps after these major findings are put in production, so to speak? Regarding this question, I think it is a different type of 'breakthrough' in that it can lead to direct target discovery for drug development, which is very close to the end of approval and clinical trials. My research institute has its strenghth in small molecule drugs but there is a much bigger world for therapeutics. In that sense I think it is closer to 'production'.